acetylcysteine has been researched along with Adenocarcinoma, Mucinous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Akhter, J; Badar, S; Glenn, D; Liauw, W; Lodh, S; Mekkawy, AH; Morris, DL; Pillai, K; Power, M; Valle, SJ | 1 |
| Bartlett, DL; Beumer, JH; Choudry, HA; Dilly, AK; Elapavaluru, A; Foley, LM; Frederick, R; Guo, J; Hitchens, TK; Honick, BD; Lee, YJ; Makala, H; Rigatti, LH; Velankar, S | 1 |
| Hu, LH; Li, ZS; Liao, Z; Liu, MH; Wang, L; Ye, B; Zou, WB | 1 |
1 trial(s) available for acetylcysteine and Adenocarcinoma, Mucinous
| Article | Year |
|---|---|
A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
Topics: Acetylcysteine; Adenocarcinoma, Mucinous; Adult; Aged; Bromelains; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Injections, Intralesional; Male; Middle Aged; Neoplasm Grading; Peritoneal Neoplasms; Radiography, Interventional | 2021 |
2 other study(ies) available for acetylcysteine and Adenocarcinoma, Mucinous
| Article | Year |
|---|---|
Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.
Topics: Acetylcysteine; Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Bromelains; Drug Resistance, Neoplasm; Humans; Mice, Nude; Mucus; Peritoneal Neoplasms; Rats, Nude; Tissue Culture Techniques; Xenograft Model Antitumor Assays | 2021 |
Continuous infusion of N-acetylcysteine by nasobiliary for advanced intraductal papillary mucinous neoplasm of bile ducts (with video).
Topics: Abdominal Pain; Acetylcysteine; Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Bile Duct Neoplasms; Bilirubin; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Endoscopic Retrograde; Expectorants; Female; Humans; Infusions, Intralesional; Pancreatic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |